about
Quantification of cells expressing markers of proliferation and apoptosis in chronic tonsilitisHelical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction ModulesThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingA small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cellsA novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activityAn intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI)The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human PrimatesGranzyme M targets topoisomerase II alpha to trigger cell cycle arrest and caspase-dependent apoptosis.Examination of survivin expression in 50 chordoma specimens--A histological and in vitro study.The role of survivin in podocyte injury induced by puromycin aminonucleosideSurvivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.Hyperoxia accelerates Fas-mediated signaling and apoptosis in the lungs of Legionella pneumophila pneumonia.Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells.Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model studyThe oncofetal gene survivin is re-expressed in osteoarthritis and is required for chondrocyte proliferation in vitroSafety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML)Down-regulation of the antisense mitochondrial non-coding RNAs (ncRNAs) is a unique vulnerability of cancer cells and a potential target for cancer therapy.Copepod population-specific response to a toxic diatom dietActivation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritisFunctional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients.Identification of novel compounds that enhance colon cancer cell sensitivity to inflammatory apoptotic ligands.The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancerEffects of ginsenoside Rh2 on growth and migration of pancreatic cancer cellsSurvivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1Critical role of a survivin/TGF-β/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cellsPreclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1.Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.Apoptotic cell signaling in cancer progression and therapyDiscovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome cCell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseHS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation.Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.Shikonin induces apoptosis in the human gastric cancer cells HGC-27 through mitochondria-mediated pathway.Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.
P2860
Q26772985-78FC7F43-783F-41B8-9938-AF26664307BBQ27677281-037A86E8-63D0-4408-9656-F69EA9E19A09Q28070036-3C5DB1BA-19C5-42C5-B8C8-5E5CF435DD58Q28482952-AE22E5CE-4EE7-4AE4-BCA1-B35FAFD4520DQ28483886-2827A4C5-9A1C-4CCA-BF01-CC4883A3A256Q28485864-1DB39659-CE91-44B6-9CA1-9B0AF23D3AE2Q28548012-C750D478-5F48-4D05-9787-35C633CBB796Q30571557-142385FD-D1AF-4138-9822-0EF098ED7ABFQ33275528-EADA56CC-E388-4F1E-BBE8-E80DCA70D645Q33580748-F05B5192-F2DE-4E17-9124-5AF559B05A4AQ33634679-CED61233-E4EC-4563-896B-D7FEAE13E63BQ33827053-27A6A092-40BA-456F-9F3B-911E2A356AAAQ33864165-C9355D2F-1F1B-4839-8A7B-95B376297973Q33919094-CF97023F-6030-4332-A382-BDB2DE0DF2FFQ33933202-2E95B56B-5245-4D4F-93EE-C2A339FEAE9FQ33951067-88BFF184-3EED-4F05-A7BF-A539E8C806ECQ34206206-1C572958-92D9-45DB-BB56-8B07B8E8C3DFQ34245117-E4294D7A-64E8-4316-9391-46A6E35ACF9EQ34442937-2649793E-522E-49A3-A9C5-67BA25299A26Q34452194-DB4729A1-8D3E-4636-86BA-8049218C4E91Q34480741-3F70B47B-4F48-4FAE-80D9-ED64EEB60A0CQ34573226-C1E65B7E-79BF-40A6-860C-BEDC26219B1CQ34584439-AB059712-8320-45CF-B050-5279EB554395Q34641361-4640E37B-0877-4F86-AB7E-A1DAC8D11EA5Q34644740-FDDAD825-AA3D-4786-A362-1B90C2CAA5E2Q34712380-E8BA1A7E-BCD5-4712-AFCF-BD998E4ED964Q34786411-3D7753B5-CD1C-4244-A309-0E21E65AD168Q35082366-BADCBFC0-9F88-4717-B4CD-12E4BDB83F5CQ35088734-5BCA186E-2BA0-464D-B926-2234AA02A6D5Q35119355-C69D9339-2040-4061-A3B6-1D89F44AC758Q35121860-E896CDE7-8000-4586-935E-D8CF6823FB57Q35161704-E0351DE0-910F-4082-B26D-72C1BDED7402Q35176353-F84D7DE8-7AAE-44D6-8CD8-374FE8602B27Q35182716-4132BA3D-CDF4-495D-ADC7-2CCDAC6670A4Q35183027-7AFEF2CC-571F-43EC-9168-EB12B3FA9E74Q35228589-C1EEF693-5473-4AF6-8637-44E5F97EA6B9Q35482150-B08E8E6E-2542-4D53-9899-8DC2512EF3B9Q35621434-7FDEFBBD-727C-4E2D-95C1-492F84196358Q35635793-69453C96-4630-4B47-86C1-A51AA0A76829Q35643014-F9850059-25CC-4485-88CA-F6D47D2807AD
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Survivin and IAP proteins in cell-death mechanisms
@ast
Survivin and IAP proteins in cell-death mechanisms
@en
type
label
Survivin and IAP proteins in cell-death mechanisms
@ast
Survivin and IAP proteins in cell-death mechanisms
@en
prefLabel
Survivin and IAP proteins in cell-death mechanisms
@ast
Survivin and IAP proteins in cell-death mechanisms
@en
P2860
P356
P1433
P1476
Survivin and IAP proteins in cell-death mechanisms
@en
P2093
Dario C Altieri
P2860
P304
P356
10.1042/BJ20100814
P407
P577
2010-09-01T00:00:00Z